Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Macimorelin in Children with Suspected Growth Hormone Deficiency: An Open-Label, Group Comparison, Dose-Escalation Trial
Open Access
- 26 August 2021
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 94 (7-8) , 239-250
Abstract
Background/Aims: Diagnosis of growth hormone deficiency (GHD) in children requires the use of provocative growth hormone (GH) stimulation tests, which can have limited reliability and are potentially contraindicated in some patients. This is the first paediatric study to test the safety, tolerability, and pharmacokinetics (PK)/pharmacodynamics (PD) of macimorelin, an oral GH secretagogue, approved for diagnosis of adult GHD. Methods: In this open-label, group comparison, single-dose escalation trial (EudraCT 2018-001988-23), sequential cohorts of patients (C1–C3) received ascending single doses of macimorelin: 0.25 (C1), 0.5 (C2), and 1.0 (C3) mg/kg. Primary endpoints were safety and tolerability, and secondary endpoints were PK/PD. Results: Twenty-four patients aged between 2 and Conclusion: All 3 doses of macimorelin had excellent safety and tolerability with PK/PD profiles in expected ranges. These results support the use of 1.0 mg/mL macimorelin in a Phase 3 test validation trial in children.Keywords
This publication has 16 references indexed in Scilit:
- Growth hormone deficiency in children: From suspecting to diagnosingIndian Pediatrics, 2017
- Understanding burden of illness for child growth hormone deficiencyQuality of Life Research, 2017
- Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I DeficiencyHormone Research in Paediatrics, 2016
- Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescenceArchives of Disease in Childhood, 2015
- Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometryEuropean Journal of Endocrinology, 2014
- Usefulness of the insulin tolerance test in patients with type 2 diabetes receiving insulin therapyJournal of Diabetes Investigation, 2013
- Macimorelin (AEZS-130)-Stimulated Growth Hormone (GH) Test: Validation of a Novel Oral Stimulation Test for the Diagnosis of Adult GH DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2013
- Diagnosis of growth hormone deficiency in childhoodCurrent Opinion in Endocrinology, Diabetes and Obesity, 2012
- Depressive tendency in children with growth hormone deficiencyJournal of Paediatrics and Child Health, 2009
- Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology WorkshopThe Journal of Clinical Endocrinology & Metabolism, 2008